Limoneira (LMNR) Expected to Post Quarterly Sales of $15.34 Million

Wall Street analysts expect Limoneira (NASDAQ:LMNR) to post $15.34 million in sales for the current quarter, Zacks reports. Two analysts have made estimates for Limoneira’s earnings. The lowest sales estimate is $13.70 million and the highest is $16.98 million. Limoneira reported sales of $15.93 million during the same quarter last year, which would suggest a negative year-over-year growth rate of 3.7%. The company is expected to issue its next quarterly earnings report on Monday, January 14th.

According to Zacks, analysts expect that Limoneira will report full-year sales of $129.98 million for the current financial year, with estimates ranging from $128.30 million to $131.66 million. For the next financial year, analysts anticipate that the business will report sales of $195.57 million, with estimates ranging from $182.44 million to $208.70 million. Zacks’ sales averages are an average based on a survey of analysts that follow Limoneira.

Limoneira (NASDAQ:LMNR) last posted its quarterly earnings data on Monday, September 10th. The company reported $0.50 EPS for the quarter, missing the Zacks’ consensus estimate of $0.55 by ($0.05). The business had revenue of $39.95 million during the quarter, compared to analysts’ expectations of $37.68 million. Limoneira had a net margin of 15.91% and a return on equity of 6.46%.

A number of research firms have recently commented on LMNR. ValuEngine upgraded Limoneira from a “hold” rating to a “buy” rating in a research report on Tuesday, July 31st. Buckingham Research boosted their price objective on Limoneira from $30.00 to $32.00 and gave the company a “buy” rating in a research report on Tuesday, September 11th. BidaskClub upgraded Limoneira from a “buy” rating to a “strong-buy” rating in a research report on Friday, June 22nd. Zacks Investment Research raised Limoneira from a “sell” rating to a “hold” rating in a research note on Wednesday, August 29th. Finally, Stifel Nicolaus initiated coverage on Limoneira in a research note on Thursday, June 28th. They issued a “buy” rating and a $30.00 price target on the stock. One investment analyst has rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $29.50.

Shares of Limoneira stock traded down $0.14 on Friday, reaching $24.80. The company’s stock had a trading volume of 130,400 shares, compared to its average volume of 85,992. The stock has a market capitalization of $453.75 million, a PE ratio of 58.62, a price-to-earnings-growth ratio of 2.61 and a beta of 0.85. Limoneira has a 52-week low of $19.62 and a 52-week high of $33.42. The company has a debt-to-equity ratio of 0.31, a current ratio of 0.99 and a quick ratio of 0.81.

The company also recently declared a quarterly dividend, which was paid on Wednesday, October 17th. Stockholders of record on Monday, October 8th were paid a $0.0625 dividend. The ex-dividend date was Thursday, October 4th. This is a positive change from Limoneira’s previous quarterly dividend of $0.05. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.01%. Limoneira’s payout ratio is currently 59.52%.

In other news, Director John W.H. Merriman sold 2,200 shares of Limoneira stock in a transaction that occurred on Thursday, September 20th. The stock was sold at an average price of $28.01, for a total value of $61,622.00. Following the sale, the director now directly owns 1,218 shares of the company’s stock, valued at $34,116.18. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 4.50% of the company’s stock.

Several large investors have recently modified their holdings of the company. Bank of Montreal Can boosted its stake in Limoneira by 6,740.2% during the third quarter. Bank of Montreal Can now owns 5,951 shares of the company’s stock worth $155,000 after buying an additional 5,864 shares during the last quarter. Essex Investment Management Co. LLC acquired a new position in Limoneira during the second quarter worth $244,000. Trexquant Investment LP acquired a new position in Limoneira during the second quarter worth $285,000. Royal Bank of Canada boosted its stake in Limoneira by 62.0% during the first quarter. Royal Bank of Canada now owns 13,333 shares of the company’s stock worth $316,000 after buying an additional 5,103 shares during the last quarter. Finally, First Trust Advisors LP boosted its stake in Limoneira by 18.0% during the second quarter. First Trust Advisors LP now owns 13,671 shares of the company’s stock worth $336,000 after buying an additional 2,082 shares during the last quarter. 42.18% of the stock is currently owned by hedge funds and other institutional investors.

About Limoneira

Limoneira Company operates as an agribusiness and real estate development company in the United States and internationally. The company operates through six segments: Fresh Lemons, Lemon Packing, Avocados, Other Agribusiness, Rental Operations, and Real Estate Development. The Fresh Lemons segment markets and sells lemons directly to food service, wholesale, and retail customers.

Recommended Story: Why is the conference call important?

Get a free copy of the Zacks research report on Limoneira (LMNR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Limoneira Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Limoneira and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply